Literature DB >> 12517540

The TNM staging system and breast cancer.

John R Benson1, Donald L Weaver, Indraneel Mittra, Mitsuhiro Hayashi.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12517540     DOI： 10.1016/s1470-2045(03)00961-6

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  16 in total

1.  Value of the metastatic lymph node ratio for predicting the prognosis of non-small-cell lung cancer patients.

Authors:  Chang-Li Wang; Yue Li; Dong-Sheng Yue; Lian-Min Zhang; Zhen-Fa Zhang; Bing-Sheng Sun
Journal:  World J Surg       Date:  2012-02       Impact factor: 3.352

2.  Targeted expression of miR-34a using the T-VISA system suppresses breast cancer cell growth and invasion.

Authors:  Laisheng Li; Xinhua Xie; Jinmei Luo; Min Liu; Shaoyan Xi; Jiaoli Guo; Yanan Kong; Minqing Wu; Jie Gao; Zeming Xie; Jun Tang; Xi Wang; Weidong Wei; Mingtian Yang; Mien-Chie Hung; Xiaoming Xie
Journal:  Mol Ther       Date:  2012-10-02       Impact factor: 11.454

3.  Prognostic factors in breast cancer: the value of the Nottingham Prognostic Index for patients treated in a single institution.

Authors:  Homa Okugawa; Daigo Yamamoto; Yoshiko Uemura; Noriko Sakaida; Masanori Yamada; Kanji Tanaka; Yasuo Kamiyama
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

4.  The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis.

Authors:  Paula M Lantz; Mahasin Mujahid; Kendra Schwartz; Nancy K Janz; Angela Fagerlin; Barbara Salem; Lihua Liu; Dennis Deapen; Steven J Katz
Journal:  Am J Public Health       Date:  2006-10-31       Impact factor: 9.308

5.  Nuclear expression of KLF6 tumor suppressor factor is highly associated with overexpression of ERBB2 oncoprotein in ductal breast carcinomas.

Authors:  Ricardo C Gehrau; Diego S D'Astolfo; Catherine I Dumur; José L Bocco; Nicolás P Koritschoner
Journal:  PLoS One       Date:  2010-01-28       Impact factor: 3.240

6.  The impact of sociodemographic, treatment, and work support on missed work after breast cancer diagnosis.

Authors:  Mahasin S Mujahid; Nancy K Janz; Sarah T Hawley; Jennifer J Griggs; Ann S Hamilton; Steven J Katz
Journal:  Breast Cancer Res Treat       Date:  2009-04-10       Impact factor: 4.872

7.  The tumor-to-breast volume ratio (TBR) predicts cancer-specific survival in breast cancer patients who underwent modified radical mastectomy.

Authors:  Jiahuai Wen; Feng Ye; Xiaojia Huang; Shuaijie Li; Lu Yang; Xiangsheng Xiao; Xiaoming Xie
Journal:  Tumour Biol       Date:  2015-12-17

8.  Racial/ethnic differences in job loss for women with breast cancer.

Authors:  Mahasin S Mujahid; Nancy K Janz; Sarah T Hawley; Jennifer J Griggs; Ann S Hamilton; John Graff; Steven J Katz
Journal:  J Cancer Surviv       Date:  2010-10-09       Impact factor: 4.442

9.  A comparison of clinicopathological features and molecular markers in british and nigerian women with breast cancer.

Authors:  Isaac D Gukas; Anne C Girling; Barnabas M Mandong; Wendy Prime; Barbara A Jennings; Samuel J Leinster
Journal:  Clin Med Oncol       Date:  2008-04-24

10.  Evolution of breast cancer management in Ireland: a decade of change.

Authors:  Helen M Heneghan; Ruth S Prichard; Amanda Devaney; Karl J Sweeney; C Malone; Ray McLaughlin; Michael J Kerin
Journal:  BMC Surg       Date:  2009-09-18       Impact factor: 2.102
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.